mouse normal hepatocyte aml 12 cell line Search Results


99
ATCC mouse aml 12 hepatocytes
Mouse Aml 12 Hepatocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse aml 12 hepatocytes/product/ATCC
Average 99 stars, based on 1 article reviews
mouse aml 12 hepatocytes - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

94
CLS Cell Lines Service GmbH alpha mouse liver 12
Compounds 5f and 4d attenuate inflammation in vitro. Effects of compounds (10 µM) on the protein levels of STAT3, IκB, and NF-κB in <t>AML-12</t> cells. ( a ) Expression levels of inflammation related-proteins in vitro. ( b – d ) Protein expression levels were normal-ized against the indicated protein. * p < 0.05 compared with the group treated with the PBS (vehicle). + p < 0.05 compared with the group treated with the LPS. Data are pre-sented as the mean ± SD.
Alpha Mouse Liver 12, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alpha mouse liver 12/product/CLS Cell Lines Service GmbH
Average 94 stars, based on 1 article reviews
alpha mouse liver 12 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Corning Life Sciences aml-12 cells
Compounds 5f and 4d attenuate inflammation in vitro. Effects of compounds (10 µM) on the protein levels of STAT3, IκB, and NF-κB in <t>AML-12</t> cells. ( a ) Expression levels of inflammation related-proteins in vitro. ( b – d ) Protein expression levels were normal-ized against the indicated protein. * p < 0.05 compared with the group treated with the PBS (vehicle). + p < 0.05 compared with the group treated with the LPS. Data are pre-sented as the mean ± SD.
Aml 12 Cells, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aml-12 cells/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
aml-12 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Procell Inc aml-12 mouse liver cells
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
Aml 12 Mouse Liver Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aml-12 mouse liver cells/product/Procell Inc
Average 90 stars, based on 1 article reviews
aml-12 mouse liver cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Keygen Biotech alpha mouse liver 12 aml-12 cells
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
Alpha Mouse Liver 12 Aml 12 Cells, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alpha mouse liver 12 aml-12 cells/product/Keygen Biotech
Average 90 stars, based on 1 article reviews
alpha mouse liver 12 aml-12 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Procell Inc 3t3-l1 cells
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
3t3 L1 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3t3-l1 cells/product/Procell Inc
Average 90 stars, based on 1 article reviews
3t3-l1 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

99
TaKaRa aml 12 cells
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
Aml 12 Cells, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aml 12 cells/product/TaKaRa
Average 99 stars, based on 1 article reviews
aml 12 cells - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

96
ATCC mouse hepatocyte cell line
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
Mouse Hepatocyte Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse hepatocyte cell line/product/ATCC
Average 96 stars, based on 1 article reviews
mouse hepatocyte cell line - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

90
BioResource International Inc aml 12 (alpha mouse liver 12) cell line
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
Aml 12 (Alpha Mouse Liver 12) Cell Line, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aml 12 (alpha mouse liver 12) cell line/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
aml 12 (alpha mouse liver 12) cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Ribobio co aml-12 cells
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
Aml 12 Cells, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aml-12 cells/product/Ribobio co
Average 90 stars, based on 1 article reviews
aml-12 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Keygen Biotech hepg2 cells
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
Hepg2 Cells, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hepg2 cells/product/Keygen Biotech
Average 90 stars, based on 1 article reviews
hepg2 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Procell Inc alpha mouse liver 12 cell line procell cl-0602
KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression <t>in</t> <t>AML-12</t> cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.
Alpha Mouse Liver 12 Cell Line Procell Cl 0602, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alpha mouse liver 12 cell line procell cl-0602/product/Procell Inc
Average 90 stars, based on 1 article reviews
alpha mouse liver 12 cell line procell cl-0602 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Compounds 5f and 4d attenuate inflammation in vitro. Effects of compounds (10 µM) on the protein levels of STAT3, IκB, and NF-κB in AML-12 cells. ( a ) Expression levels of inflammation related-proteins in vitro. ( b – d ) Protein expression levels were normal-ized against the indicated protein. * p < 0.05 compared with the group treated with the PBS (vehicle). + p < 0.05 compared with the group treated with the LPS. Data are pre-sented as the mean ± SD.

Journal: International Journal of Molecular Sciences

Article Title: Novel Benzoxazoles Containing 4-Amino-Butanamide Moiety Inhibited LPS-Induced Inflammation by Modulating IL-6 or IL-1β mRNA Expression

doi: 10.3390/ijms23105331

Figure Lengend Snippet: Compounds 5f and 4d attenuate inflammation in vitro. Effects of compounds (10 µM) on the protein levels of STAT3, IκB, and NF-κB in AML-12 cells. ( a ) Expression levels of inflammation related-proteins in vitro. ( b – d ) Protein expression levels were normal-ized against the indicated protein. * p < 0.05 compared with the group treated with the PBS (vehicle). + p < 0.05 compared with the group treated with the LPS. Data are pre-sented as the mean ± SD.

Article Snippet: The human keratinocytes HaCaT or the alpha mouse liver 12 (AML-12) cells were obtained from Cell Lines Service GmbH (Eppelheim, Germany).

Techniques: In Vitro, Expressing

KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression in AML-12 cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.

Journal: Heliyon

Article Title: Oral administration of kynurenic acid delays the onset of type 2 diabetes in Goto-Kakizaki rats

doi: 10.1016/j.heliyon.2023.e17733

Figure Lengend Snippet: KYNA enhances mRNA and protein expression of hepatic UCP genes. (A, B) Real-time quantitative PCR analysis (n = 6) of gene expression in HepG2 cells after 48 h of 10 μmol/L (K10) or 100 μmol/L (K100) KYNA treatment compared with control group (white punctuated line). (C, D) Western blot analysis of UCP2 expression in HepG2 cells after 48 h of 100 μmol/L KYNA treatment (n = 3), (E, F) Real-time quantitative PCR analysis of gene expression in HepG2 cells after 2 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (G) Quantitative PCR analysis of gene expression in AML-12 cells after 48 h treatment with 10 μmol/L (K10) or 100 μmol/L (K100) KYNA (n = 6), (H) Expression of hepatic energy metabolism genes in GK rats after oral administration 25 mg/kg KYNA (KYNA) or NaCl (Ctrl) (I) Comprehensive analysis of transcriptomic pathways in KYNA-treated HepG2 cells after 48 h KYNA, 100 μmol/L (n = 3). Statistical analysis using t -test, * p < 0.05.

Article Snippet: HepG2 human liver cells and AML-12 mouse liver cells (Procell, China) were cultured in MEM basal medium (Gibco, China) containing 10% fetal bovine plasma (Gibco, Australia).

Techniques: Expressing, Real-time Polymerase Chain Reaction, Western Blot